340 related articles for article (PubMed ID: 31970565)
1. The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer.
Xu S; Tan S; Wu T; Gu J; Xu L; Che X
Lasers Med Sci; 2020 Oct; 35(8):1695-1701. PubMed ID: 31970565
[TBL] [Abstract][Full Text] [Related]
2. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
[No Abstract] [Full Text] [Related]
3. Randomized study of intravesical pirarubicin chemotherapy with low and intermediate-risk nonmuscle-invasive bladder cancer in Japan: Comparison of a single immediate postoperative intravesical instillation with short-term adjuvant intravesical instillations after transurethral resection.
Naya Y; Mikami K; Takaha N; Inoue Y; Fujihara A; Kanazawa M; Nakanishi H; Miyashita H; Ukimura O
Medicine (Baltimore); 2018 Oct; 97(42):e12740. PubMed ID: 30334959
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N; Hatakeyama S; Momota M; Kido K; Narita T; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
Urol Oncol; 2020 Aug; 38(8):684.e17-684.e24. PubMed ID: 32278732
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
Tanimoto R; Saika T; Ebara S; Kobayashi Y; Nasu R; Yamada D; Takamoto H; Miyaji Y; Nasu Y; Tsushima T; Kumon H
World J Urol; 2018 Jun; 36(6):889-895. PubMed ID: 29387931
[TBL] [Abstract][Full Text] [Related]
6. Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients.
Zhou W; Wang W; Wu W; Yan T; Du G; Liu H
BMC Urol; 2020 Mar; 20(1):30. PubMed ID: 32188429
[TBL] [Abstract][Full Text] [Related]
7. A retrospective comparison of thulium laser en bloc resection of bladder tumor and plasmakinetic transurethral resection of bladder tumor in primary non-muscle invasive bladder cancer.
Li K; Xu Y; Tan M; Xia S; Xu Z; Xu D
Lasers Med Sci; 2019 Feb; 34(1):85-92. PubMed ID: 30171441
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Sylvester RJ; Oosterlinck W; Holmang S; Sydes MR; Birtle A; Gudjonsson S; De Nunzio C; Okamura K; Kaasinen E; Solsona E; Ali-El-Dein B; Tatar CA; Inman BA; N'Dow J; Oddens JR; Babjuk M
Eur Urol; 2016 Feb; 69(2):231-44. PubMed ID: 26091833
[TBL] [Abstract][Full Text] [Related]
9. [The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
Tochigi T; Sakurada Y; Aoki H; Kawamura S; Itou S; Satou I; Tateno H
Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):610-6. PubMed ID: 23120995
[TBL] [Abstract][Full Text] [Related]
10. Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a single-institution nonrandomized concurrent controlled trial.
Zhou J; Li L; Li X; Yu Q; Cui S; Shu K; Liu J; Liu J; Ding D; Du T
Int J Hyperthermia; 2019; 36(1):868-875. PubMed ID: 31452420
[No Abstract] [Full Text] [Related]
11. Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
Li NC; Ye ZQ; Na YQ;
Chin Med J (Engl); 2013; 126(15):2805-9. PubMed ID: 23924446
[TBL] [Abstract][Full Text] [Related]
12. A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
Sun F; Zhao R; Zhu Y; Cui D; Wang X; Han B; Liang S; Liu H; Sun X; Zhao F; Xu D; Xia S
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1099-1107. PubMed ID: 28421294
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice.
Murakami K; Hamada A; Teramoto Y; Matsumoto K; Kita Y; Saito R; Yamasaki T; Matsui Y; Inoue T; Ogawa O; Kobayashi T
Clin Genitourin Cancer; 2019 Oct; 17(5):e1003-e1010. PubMed ID: 31402280
[TBL] [Abstract][Full Text] [Related]
14. Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer.
Kageyama S; Maeda K; Kubota S; Yoshida T; Osafune T; Arai Y; Soga H; Nishikawa Z; Sakano Y; Takimoto K; Kim CJ; Chano T; Kawauchi A
In Vivo; 2021; 35(2):1141-1145. PubMed ID: 33622912
[TBL] [Abstract][Full Text] [Related]
15. Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation.
Sun JX; An Y; Xu MY; Liu CQ; Xu JZ; Xia QD; Wang SG
Front Oncol; 2023; 13():1133161. PubMed ID: 37476386
[TBL] [Abstract][Full Text] [Related]
16. NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP.
Zhou Q; Ding W; Weng Y; Ding G; Xia G; Xu J; Xu K; Ding Q
Chemotherapy; 2018; 63(4):191-197. PubMed ID: 30125887
[TBL] [Abstract][Full Text] [Related]
17. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
Li Q; Xu T; Wang XF
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
[TBL] [Abstract][Full Text] [Related]
19. Expressions of P-Glycoprotein, Multidrug Resistance Protein 1 and Annexin A2 as Predictive Factors for Intravesical Recurrence of Bladder Cancer after the Initial Transurethral Resection and Immediate Single Intravesical Instillation of Adriamycin.
Sawazaki H; Ito K; Asano T; Kuroda K; Horiguchi A; Tsuda H; Asano T
Asian Pac J Cancer Prev; 2021 May; 22(5):1459-1466. PubMed ID: 34048174
[TBL] [Abstract][Full Text] [Related]
20. Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer.
Assem A; Kassem A; Sherif M; Lotfi A; Abdelwahed M
Int Urol Nephrol; 2023 Dec; 55(12):3103-3109. PubMed ID: 37639155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
